Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA Stability

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...

RNA Structure

RNA Structure

Overview
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...

RNA Splicing

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...

Types of RNA

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

What is Genetic Engineering?

What is Genetic Engineering?

Transfer RNA Synthesis

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Synthesis and biophysical evaluation of C-5-triazolyl-functionalized morpholino-thymidine analogs.

Organic & biomolecular chemistry·2026

Same author

Acyclic serinol nucleic acid modification of siRNAs overcomes seed region mediated off-target effects while maintaining potency.

Nucleic acids research·2026

Same author

A metal ion-dependent mechanism promoting gain of function in NEIL1 variants.

International journal of radiation biology·2026

Same author

Synthesis of siRNAs containing carbocyclic nucleotides and the role of cyclopentane conformation in RNAi activity.

RSC chemical biology·2026

Same author

New targets and procedures for validating the valence geometry of nucleic acid structures.

Nucleic acids research·2026

Same author

C‑Nucleosides Stabilize RNA by Reducing Nucleophilicity at 2'-OH.

ACS central science·2025

Search research articles

Related Experiment Video

Updated: Jan 27, 2026

Nanomanipulation of Single RNA Molecules by Optical Tweezers

Nanomanipulation of Single RNA Molecules by Optical Tweezers

Published on: August 20, 2014

Re-Engineering RNA Molecules into Therapeutic Agents.

Martin Egli¹, Muthiah Manoharan²

¹Department of Biochemistry, School of Medicine , Vanderbilt University , Nashville , Tennessee 37232 , United States.

Accounts of Chemical Research

|March 27, 2019

Summary

This summary is machine-generated.

Chemically modified nucleic acids, including 2'-F RNA and phosphorothioates, are crucial for therapeutics. Optimizing siRNA modifications requires understanding regio-specific interactions with Argonaute 2 for enhanced efficacy.

More Related Videos

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Related Experiment Videos

Last Updated: Jan 27, 2026

Nanomanipulation of Single RNA Molecules by Optical Tweezers

Nanomanipulation of Single RNA Molecules by Optical Tweezers

Published on: August 20, 2014

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Area of Science:

Nucleic acid chemistry
Medicinal chemistry
Biotechnology

Background:

Chemical modification of nucleic acids began shortly after DNA's discovery, with early analogues like 2 eal-F RNA, 2 eal-OMe RNA, and phosphorothioates forming the basis of current therapeutics.
Advancements in oligonucleotide synthesis have led to second and third-generation analogues (e.g., MOE-RNA, BNAs), expanding the toolkit for creating modified nucleic acids beyond base, sugar, and backbone alterations.

Purpose of the Study:

To review current strategies for chemically modifying small interfering RNAs (siRNAs).
To emphasize the importance of regio-specific interactions between oligonucleotides and Argonaute 2 (Ago2) in optimizing siRNA efficacy.
To highlight how structural insights guide the design of novel siRNA therapeutics.

Main Methods:

Review of established and emerging nucleic acid modification strategies.
Analysis of regio-specific interactions between siRNA components and Ago2 domains (MID, PIWI, PAZ).
Integration of crystallographic data and molecular modeling for structure-based design.

Main Results:

Chemical modifications significantly impact nucleic acid pairing, stability, conformation, and interactions with proteins involved in cellular processes.
Uniform siRNA modifications are less effective; tailored modifications targeting specific Ago2 interaction sites are necessary for optimal therapeutic efficacy.
The first siRNA therapeutic approval demonstrates the potential of chemically modified nucleic acids.

Conclusions:

Understanding the intricate interplay between modified siRNAs and Ago2 is key to developing effective RNA interference-based therapies.
A comprehensive approach combining chemical modification, structural biology, and computational modeling accelerates the design of next-generation siRNA therapeutics.
Chemically modified nucleic acids hold immense promise for treating various diseases, as evidenced by recent regulatory approvals.